The latest closing stock price for SpringWorks Therapeutics as of April 28, 2025 is 46.18.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $1,041 today, roughly 1 times their original investment - a 12.62% compound annual growth rate over 6 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 62.00, which is 34.3% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 28.21, which is 38.9% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 39.61.
An investor who bought $1,000 worth of SpringWorks Therapeutics stock at the IPO in 2019 would have $1,041 today, roughly 1 times their original investment - a 12.62% compound annual growth rate over 6 years.
The all-time high SpringWorks Therapeutics stock closing price was 93.59 on February 24, 2021.
The SpringWorks Therapeutics 52-week high stock price is 62.00, which is 34.3% above the current share price.
The SpringWorks Therapeutics 52-week low stock price is 28.21, which is 38.9% below the current share price.
The average SpringWorks Therapeutics stock price for the last 52 weeks is 39.61.